Anja Geerts

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu, Stephen A. Harrison, Sven Francque et al. · Gastroenterology · 2016 · 993 citations · Full text

Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆

Sander Lefere, Tobias Puengel, Jana Hundertmark et al. · Journal of Hepatology · 2020 · 277 citations · Full text

Inflammation, Molecular Pharmacology, Pan-ppar Agonists +11

Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease

Sara Van de Veire, Ingeborg Stalmans, Femke Heindryckx et al. · Cell · 2010 · 252 citations · Full text

Ocular Disease, Eye Disease, Ophthalmology +7

The paradox of the unfolded protein response in cancer.

Yves‐Paul Vandewynckel, Debby Laukens, Anja Geerts et al. · PubMed · 2013 · 169 citations

Apoptosis, Cell Death, Cancer Biology +18